D609 - CAS# 83373-60-8 Catalog No.:M10949-10 The PKC inhibitor has no

The PKC inhibitor has no effect on vascular responses in normoglycemic and TR animals

also known as OGT 918 and NB-DNJ

1047644-62-1

Food and Drug Administration (FDA) approved Ibandronate as a daily treatment for post-menopausal osteoporosis

D609 - CAS# 83373-60-8 Catalog No.:M10949-10 The PKC inhibitor has noD 609, also known as D 609 free, is a phospholipase C inhibitor potentially for the treatment of pancreatic cancer. D 609, an inhibitor of PC PLC and sphingomyelin synthase, strongly inhibited myogenic tone and had no effect on depolarization induced contraction. D 609 appeared to act by lowering cytoplasmic Ca(2+) concentration to levels below those that activate contraction. Product information CAS Number: 83373 60 8 Molecular Weight: 266. 46